# Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

> **NCT00422240** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 1668 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene/Benzoyl Peroxide
- **DRUG:** Adapalene Gel, 0.1%
- **DRUG:** Benzoyl Peroxide Gel 2.5%
- **DRUG:** Gel Vehicle

## Key facts

- **NCT ID:** NCT00422240
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06-27
- **Primary completion:** 2007-07-12
- **Final completion:** 2007-07-12
- **Target enrollment:** 1668 (ACTUAL)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422240, "Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00422240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*